Business
Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant
Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant\n \n \nEaston Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant\n \n TORONTO, ON--(Marketwired - Dec 1, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has arranged to have its completed 2013 audit to be handed over to two American and Canadian based Medical Marihuana Growers whom the company has had ongoing communications with. As previously stated, grower details are expected to be disclosed within the second week of December as per allowances made on due diligence documentation and agreements.\n Easton has been considering entering the lucrative Medical Marijuana industry mainly through the acquisition route. Current acquisition candidates have insisted on an independent audit on its 2013 year end financial statements prior to considering and accepting restricted shares of Easton Pharmaceuticals common stock as part of its ongoing negotiations. Current auditor has been vetted by the candidates to ensure that standards would be acceptable to all parties. \n In other developments involving Easton's current Canadian medical marijuana facility / initiative, the applicants have undergone communications with Health Canada and are hoping to be one of the next few company's processed by health Canada. There have been expectations that Health Canada would review, inspect and finalize applications by end of year and start approving applicants early into the new year (2015). Easton Pharmaceuticals has received a full financing commitment through an accredited private Canadian investor, contingent on receiving an MMPR license. In addition a second investor option from a New York based accredited investor have provided Easton with a commitment for up to $5,000,000 in financing who have previously financed the company in the amount of $1,000,000 .\n Easton Pharmaceuticals is striving to become not just another player in the industry but a potent company that will deliver a great value proposition to its shareholders and partners. \n About Easton Pharmaceuticals\n Easton Pharmac...